期刊文献+

抗角蛋白抗体、抗RA33抗体及类风湿因子在老年起病的类风湿关节炎中的意义 被引量:5

下载PDF
导出
摘要 目的探讨抗角蛋白抗体(AKA)、抗RA33抗体与类风湿因子(RF)对老年起病的类风湿关节炎(EORA)诊断的特异性和敏感性,探讨以上3种抗体与EORA病情活动性之间的相关性。方法对39例EORA患者、82例非老年起病的类风湿关节炎(NEORA)患者及30例正常老年人的血清同时进行了AKA(间接免疫荧光法)、抗RA33抗体(ELISA法)与RF(免疫比浊法)的测定,并对以上3种抗体与EORA病情活动性之间的关系进行了分析。结果39例EORA患者中,AKA、抗RA33抗体及RF的阳性率分别为30.8%(12/39)、35.9%(14/39)及64.1%(25/39)。82例NEORA患者中,AKA、抗RA33抗体及RF的阳性率分别为43.9%(36/82)、47.6%(39/82)及81.7%(67/82)。30例正常老年人中,均仅有1例检测到AKA及抗RA33抗体,有2例检测到RF低滴度阳性。AKA、抗RA33抗体及RF在39例EORA患者中的敏感性分别为30.8%、35.9%及64.1%,特异性分别为99.7%、99.7%及93.3%。AKA及抗RA33抗体在EORA组及NEORA组的敏感性均无明显差异,而RF在NEO-RA组的敏感性则显著高于EORA组。以28处关节疾病活动度积分(DAS28)来评价EORA患者的病情活动性,在39例EORA患者中,AKA、抗RA33抗体及RF阳性组的病情活动性均显著高于各自阴性对照组。结论AKA、抗RA33抗体及RF有助于EORA的诊断及病情活动性判断。
出处 《广东医学》 CAS CSCD 北大核心 2007年第10期1644-1646,共3页 Guangdong Medical Journal
基金 广东省深圳市医学重点学科建设基金资助项目(编号:2005C10)
  • 相关文献

参考文献14

  • 1DEAL C L, MEENAN R F, GOLDENBERG D L, et al. The clinical features of elderly - onset rheumatoid arthritis. A comparison with younger - onset disease of similar duration [ J ]. Arthritis Rheum, 1985, 28(9): 987-94.
  • 2TUTUNCU Z, REED G, KREMER J, et al. Do patients with older- onset rheumatoid arthritis receive less aggressive treatment? [J]. Ann Rheum Dis, 2005, 65(9) :1 226 -1 229.
  • 3OLIVIERI I, PALAZZI C, PERUZ G, et al. Management issues with elderly - onset rheumatoid arthritis : an update [ J ]. Drugs Aging, 2005, 22(10): 809-822.
  • 4HELLIER J P, ELIAOU J F, DAURES J P, et al. HLA - DRB1 genes and patients with late onset rheumatoid arthritis [ J ]. Ann Rheum Dis, 2001, 60(5) : 531 -533.
  • 5魏锦,袁国华,黄慈波,周京国,唐中,蔚芃,杨明辉.老年类风湿关节炎患者43例临床分析[J].中华老年医学杂志,2004,23(1):27-29. 被引量:30
  • 6栗占国.老年类风湿关节炎的治疗[J].老年医学与保健,2003,9(3):137-140. 被引量:19
  • 7施桂英,袁国华.老年类风湿关节炎[J].风湿病学杂志,1997,2(3):3-5. 被引量:29
  • 8吴东海.老年发病的类风湿关节炎的诊治进展[J].实用老年医学,2002,16(4):180-182. 被引量:11
  • 9OLIVO D, D' AMORE M, MATrACE - RASO F, et al. Clinical and laboratory features at onset of polymyalgia rheumatica(PMR) and elderly onset of rheumatoid arthritis in PGR - 1 ike prvsention : a comparision of two groups of patients[J]. Arch Gerontol Geriatr, 1996, s(5) : 527 -533.
  • 10VASILIAUSKIENE L, WILLK A, HOIER MADSEN M. Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients withrheumatoidarthritis[ J]. Ann RheumDis, 2001,60(5): 459-466.

二级参考文献22

  • 1张乃峥,施全胜,张雪哲,沙力进,王永和,赵淑霞,芦世华,于桂兰,屈辉.膝骨关节炎的流行病学调查[J].中华内科杂志,1995,34(2):79-83. 被引量:359
  • 2栗占国.类风湿关节炎[A].施桂英 主编.关节炎概要:第1版[C].北京:中国医药科技出版社,2000.267-270.
  • 3蔡小青,曾庆馀,周修国,黄少弼,肖征宇.抗鼠食管角质层抗体的检测及其临床意义[J].汕头大学医学院学报,1997(1):22-25. 被引量:5
  • 4O'Dell JR. Left R, Paulsen G, et al. Trealment of rheumatoid arthritis with methotrexate and hydmxyehloroqulne, methotrexate and sulfasalazine, or a combination of the three medications: results of a two - year. randomized, double - blind, placebo - controlled trial. Arthritis Rheum, 2002, 46(5): 1164 - 1170.
  • 5Kremer JM. Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arlhritis despite stable doses of merhotrexate. A randomized, double- blind,placebo - controlled trial. Ann Intern Med, 2002, 137(9): 726 -733.
  • 6Totokawa S. Furuya T, Nakajima A, et al. Effects of low dose methotrexate Iherapy in rheumaloid arthritis: a comparison of three different dosage regimens. Ryumachi, 1997, 37 (5): 681 -687.
  • 7Glennas A, Kvien TK, Andrup O, et al. Auranofin is safe and superior to placebo in elderly - onset rheumatoid arthritis. Br J Rheum, 1997, 36:870 - 877.
  • 8Favalli EG, Sinigaglia L, Varenna M, et al. Drug- induced lupus following treatment with infliximab in rheumatoid arthritis.Lupus,2002, 11 ( 11 ) :753 - 755.
  • 9Brown SL, Greene MH, Gershon SK. et al. Tumor necrosis factor antagonist therapy and lymphnma development: twenty- six cases reported to the Food and Drug administration. Arthritis Rheum, 2002,46( 12): 3151 - 3158.
  • 10Lockie LM, Gomez E, Smith DM.Low dose adrenocorticosteroids in the management of elderly patients and summary of efficacy in the long-term treatment of 97 patients .Semin Arthritis Rheum,1983,12(4):373 - 381.

共引文献71

同被引文献109

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部